Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

Awasthi S, Ezelle H, Hassel BA, Hamburger AW.

Mol Cell Biochem. 2015 Jul;405(1-2):177-86. doi: 10.1007/s11010-015-2409-z. Epub 2015 Apr 17.

PMID:
25876877
2.

RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry.

Malathi K, Siddiqui MA, Dayal S, Naji M, Ezelle HJ, Zeng C, Zhou A, Hassel BA.

MBio. 2014 Oct 28;5(6):e02012. doi: 10.1128/mBio.02012-14.

3.

RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response.

Brennan-Laun SE, Li XL, Ezelle HJ, Venkataraman T, Blackshear PJ, Wilson GM, Hassel BA.

J Biol Chem. 2014 Nov 28;289(48):33629-43. doi: 10.1074/jbc.M114.589556. Epub 2014 Oct 9.

PMID:
25301952
4.

Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.

Long TM, Nisa S, Donnenberg MS, Hassel BA.

Infect Immun. 2014 Jul;82(7):2802-14. doi: 10.1128/IAI.00105-14. Epub 2014 Apr 14.

5.

RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting.

Brennan-Laun SE, Ezelle HJ, Li XL, Hassel BA.

J Interferon Cytokine Res. 2014 Apr;34(4):275-88. doi: 10.1089/jir.2013.0147. Review.

6.

RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer.

Long TM, Chakrabarti A, Ezelle HJ, Brennan-Laun SE, Raufman JP, Polyakova I, Silverman RH, Hassel BA.

Inflamm Bowel Dis. 2013 May;19(6):1295-305. doi: 10.1097/MIB.0b013e318281f2fd.

7.

Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia.

Lee TY, Ezelle HJ, Venkataraman T, Lapidus RG, Scheibner KA, Hassel BA.

J Interferon Cytokine Res. 2013 Jan;33(1):34-42. doi: 10.1089/jir.2012.0062. Epub 2012 Oct 31.

8.

Coordinated expression of tristetraprolin post-transcriptionally attenuates mitogenic induction of the oncogenic Ser/Thr kinase Pim-1.

Mahat DB, Brennan-Laun SE, Fialcowitz-White EJ, Kishor A, Ross CR, Pozharskaya T, Rawn JD, Blackshear PJ, Hassel BA, Wilson GM.

PLoS One. 2012;7(3):e33194. doi: 10.1371/journal.pone.0033194. Epub 2012 Mar 8.

9.

Pathologic effects of RNase-L dysregulation in immunity and proliferative control.

Ezelle HJ, Hassel BA.

Front Biosci (Schol Ed). 2012 Jan 1;4:767-86. Review.

10.

A central role for RNA in the induction and biological activities of type 1 interferons.

Li XL, Ezelle HJ, Hsi TY, Hassel BA.

Wiley Interdiscip Rev RNA. 2011 Jan-Feb;2(1):58-78. doi: 10.1002/wrna.32. Epub 2010 Aug 24. Review.

PMID:
21956969
11.

Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence.

Andersen JB, Mazan-Mamczarz K, Zhan M, Gorospe M, Hassel BA.

RNA Biol. 2009 Jul-Aug;6(3):305-15. Epub 2009 Jul 23.

12.

Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice.

Zhang Y, Lu Y, Zhou H, Lee M, Liu Z, Hassel BA, Hamburger AW.

BMC Cell Biol. 2008 Dec 18;9:69. doi: 10.1186/1471-2121-9-69.

13.

An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity.

Li XL, Ezelle HJ, Kang TJ, Zhang L, Shirey KA, Harro J, Hasday JD, Mohapatra SK, Crasta OR, Vogel SN, Cross AS, Hassel BA.

Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20816-21. doi: 10.1073/pnas.0807265105. Epub 2008 Dec 15.

14.

UBE1L causes lung cancer growth suppression by targeting cyclin D1.

Feng Q, Sekula D, Guo Y, Liu X, Black CC, Galimberti F, Shah SJ, Sempere LF, Memoli V, Andersen JB, Hassel BA, Dragnev K, Dmitrovsky E.

Mol Cancer Ther. 2008 Dec;7(12):3780-8. doi: 10.1158/1535-7163.MCT-08-0753.

15.

Post-transcriptional regulation of RNase-L expression is mediated by the 3'-untranslated region of its mRNA.

Li XL, Andersen JB, Ezelle HJ, Wilson GM, Hassel BA.

J Biol Chem. 2007 Mar 16;282(11):7950-60. Epub 2007 Jan 19.

16.

Role of 2-5A-dependent RNase-L in senescence and longevity.

Andersen JB, Li XL, Judge CS, Zhou A, Jha BK, Shelby S, Zhou L, Silverman RH, Hassel BA.

Oncogene. 2007 May 10;26(21):3081-8. Epub 2006 Nov 20.

PMID:
17130839
17.

The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?

Andersen JB, Hassel BA.

Cytokine Growth Factor Rev. 2006 Dec;17(6):411-21. Epub 2006 Nov 13. Review.

PMID:
17097911
18.

Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.

Nakanishi T, Bailey-Dell KJ, Hassel BA, Shiozawa K, Sullivan DM, Turner J, Ross DD.

Cancer Res. 2006 May 15;66(10):5007-11. Erratum in: Cancer Res. 2007 May 1;67(9):4535.

19.

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer.

Andersen JB, Aaboe M, Borden EC, Goloubeva OG, Hassel BA, Orntoft TF.

Br J Cancer. 2006 May 22;94(10):1465-71.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk